In vivo Reduction of Amyloid-β by a Mutant Copper Transporter
Cu ions have been suggested to enhance the assembly and pathogenic potential of the Alzheimer's disease$amyloid\!-\!\beta\>(A\beta)$peptide. To explore this relationship in vivo, toxic-milk (txJ) mice with a mutant ATPase7b transporter favoring elevated Cu levels were analyzed in combination...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 100; no. 24; pp. 14193 - 14198 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
25-11-2003
National Acad Sciences |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cu ions have been suggested to enhance the assembly and pathogenic potential of the Alzheimer's disease$amyloid\!-\!\beta\>(A\beta)$peptide. To explore this relationship in vivo, toxic-milk (txJ) mice with a mutant ATPase7b transporter favoring elevated Cu levels were analyzed in combination with the transgenic (Tg) CRND8 amyloid precursor protein mice exhibiting robust Aβ deposition. Unexpectedly, TgCRND8 mice homozygous for the recessive txJmutation examined at 6 months of age exhibited a reduced number of amyloid plaques and diminished plasma Aβ levels. In addition, homozygosity for txJincreased survival of young TgCRND8 mice and lowered endogenous CNS Aβ at times before detectable increases in Cu in the CNS. These data suggest that the beneficial effect of the txJmutation on CNS Aβ burden may proceed by a previously undescribed mechanism, likely involving increased clearance of peripheral pools of Aβ peptide. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 Edited by Thomas C. Südhof, University of Texas Southwestern Medical Center, Dallas, TX, and approved September 16, 2003 This paper was submitted directly (Track II) to the PNAS office. To whom correspondence should be addressed at: Center for Research in Neurodegenerative Diseases, University of Toronto, 6 Queen's Park Crescent West, Toronto, ON, Canada M5H 3S2. E-mail: david.westaway@utoronto.ca. Abbreviations: Aβ, amyloid-β; AD, Alzheimer's disease; APP, amyloid precursor protein; sAPP, secreted APP fragments; CSF, cerebrospinal fluid; LSD, least significant difference; Tg, transgenic. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.2332851100 |